image
Healthcare - Medical - Devices - NASDAQ - US
$ 0.7015
0.253 %
$ 54.6 M
Market Cap
-1.2
P/E
CASH FLOW STATEMENT
-38.8 M OPERATING CASH FLOW
7.28%
-383 K INVESTING CASH FLOW
52.36%
1.02 M FINANCING CASH FLOW
485.63%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Hyperfine, Inc.
image
00(10m)(10m)(20m)(20m)(30m)(30m)(40m)(40m)(50m)(50m)(60m)(60m)(70m)(70m)(80m)(80m)202020202021202120222022202320232024202420252025
Net Income -40.7 M
Depreciation & Amortization 1.01 M
Capital Expenditures -383 K
Stock-Based Compensation 4.36 M
Change in Working Capital -3.62 M
Others -1.6 M
Free Cash Flow -39.2 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019
OPERATING CASH FLOW
Net Income (40.7) (44.2) (73.2) (64.9) (23.4) (19.4)
Depreciation & Amortization 1.0 1.1 1.0 0.7 0.3 0.1
Deferred Income Tax 0 0 0 1.1 0.2 0
Stock Based Compensation 4.4 4.7 10.7 6.9 1.1 0.9
Other Operating Activities 0.2 0.2 91 K 10 K 44 K 4 K
Change in Working Capital (3.6) (3.6) (10.9) 9.0 0.3 2 K
Cash From Operations (38.8) (41.8) (72.3) (47.2) (21.5) (18.4)
INVESTING CASH FLOW
Capital Expenditures (0.4) (0.8) (0.6) (2.7) (1.6) (0.2)
Other Items 0 0 0 0 0 0
Cash From Investing Activities (0.4) (0.8) (0.6) (2.7) (1.6) (0.2)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0
Total Debt Repaid 0 0 0 (0.2) 0.2 (1.0)
Dividends Paid 0 0 0 0 0 0
Other Financing Activities 0.2 0.2 7 K 176.9 60.8 5.7
Cash From Financing Activities 1.0 0.2 7 K 176.8 60.9 4.7
CHANGE IN CASH
Net Change In Cash (38.1) (42.4) (72.9) 126.9 37.8 (13.9)
FREE CASH FLOW
Free Cash Flow (39.1) (42.6) (72.9) (49.9) (23.1) (18.6)